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Cell adhesion to the extracellular matrix inhibits apo-
ptosis, but the molecular mechanisms underlying the
signals transduced by different matrix components are
not well understood. Here, we examined integrin-medi-
ated antiapoptotic signals from laminin-10/11 in com-
parison with those from fibronectin, the best character-
ized extracellular adhesive ligand. We found that the
activation of protein kinase B/Akt in cells adhering to
laminin-10/11 can rescue cell apoptosis induced by se-
rum removal. Consistent with this, wortmannin, a spe-
cific inhibitor of phosphatidylinositol 3-kinase, or ec-
topic expression of a dominant-negative mutant of Akt
selectively accelerated cell death upon serum removal.
In contrast to laminin-10/11, fibronectin rescued cells
from serum depletion-induced apoptosis mainly
through the extracellular signal-regulated kinase path-
way. Cell survival on fibronectin but not laminin was
significantly reduced by treatment with PD98059, a spe-
cific inhibitor of mitogen- or extracellular signal-regu-
lated kinase kinase-1 (MEK1) and by expression of a
dominant-negative mutant of MEK1. Laminin-10/11 was
more potent than fibronectin in preventing apoptosis
induced by serum depletion. These results, taken to-
gether, demonstrate laminin-10/11 potency as a survival
factor and demonstrate that different extracellular ma-
trix components can transduce distinct survival signals
through preferential activation of subsets of multiple
integrin-mediated signaling pathways.
Cell adhesion to the ECM1 generates intracellular signals
that modulate cell proliferation, survival, and differentiation
(1, 2). Normal epithelial cells deprived of matrix attachment
undergo programmed cell death, a form of apoptosis termed
anoikis (3). Malignant transformation by oncogenic Ras can
prevent this process of apoptosis after denial of ECM attach-
ment (3) or withdrawal of survival factors (4).
One approach to study the effects of ECM signals independ-
ently of signals from other extracellular sources has been to
deprive cells of serum and then to analyze the effects of specific
ECM ligands on cellular functions such as adhesion, migration,
and survival. Using this approach, many cell biologic functions
of ECM signals have been elucidated (2). Most studies of inte-
grin-mediated signaling events have been performed on cells
adhering to FN through the 51 integrin, which seems to be
involved in regulating apoptosis triggered by serum depriva-
tion in many cell types (5, 6). This integrin has also been
reported to protect neuronal cells against apoptosis triggered
by -amyloid peptide (7). In breast epithelial cells, the 61
integrin receptor for laminin-1 has been shown to cooperate
with insulin-signaling pathways to protect cells from apoptosis
(8). In endothelial cells, functional inhibition of the v3 inte-
grin can lead to programmed cell death (9). Thus, several
distinct integrins have been implicated in protection against
apoptosis in different cell types. However, the signaling events
transduced by the 31 integrin, the major receptor for lami-
nin-10/11 (LN-10/11) and LN-5, remain unclear. In addition, it
is also not known whether 31 integrin-mediated signals dif-
fer from those transduced by the 51 integrin.
Several signal transduction components, including focal ad-
hesion kinase (FAK) (10–12), phosphatidylinositol 3-kinase (PI
3-kinase) (8, 13, 14), extracellular signal-regulated kinase
(ERK) (15–17), and c-Jun NH2-terminal kinase (18), have been
implicated in the mechanisms underlying anoikis (19). FAK
has been proposed to couple integrins and cytoskeletal proteins
to multiple signaling pathways. Several lines of evidence sug-
gest that integrin activation of signaling pathways involving PI
3-kinase, ERK, and c-Jun NH2-terminal kinase require FAK
(12, 18, 20–23). However, some studies suggest that integrins
are able to activate at least some of these pathways independ-
ently of FAK (24–26). Recently, increasing evidence has
emerged showing that PI 3-kinase and its downstream effector
Akt play key roles in the regulation of cell survival. For exam-
ple, signals through the PI 3-kinase/Akt pathway protect Ma-
din-Darby canine kidney cells against apoptosis mediated by
denial of cell anchorage or by radiation (27). It was found that
cell death in this system was inhibited by expression of a
constitutively activated form of Akt (13, 27). On the other hand,
the ERK pathway has also been found to enhance cell survival
(28, 29).
Laminins are the major components of the basement mem-
brane. Cells bind directly to laminins via a subset of integrins
(30) and other nonintegrin receptors, such as -dystroglycans
(31). All laminins are composed of , , and  chains. The
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5-containing laminins, LN-10 (511) and LN-11 (521) are
widely expressed in fetal and adult tissues (32, 33). Recently,
we purified LN-10/11 from conditioned medium of A549 human
lung carcinoma cells and found that the 31 integrin is the
preferred receptor for LN-10/11 (34, 35). LN-10/11 is more
active than FN in promoting cell migration, and it preferen-
tially activates Rac, but not Rho, via the p130cas-CrkII-
DOCK180 pathway. Cells adhering to FN develop stress fibers
and focal contacts, whereas cells adhering to LN-10/11 do not,
suggesting that LN-10/11 and FN have distinct effects on inte-
grin-mediated cell spreading and migration (36).
In this study, the first goal was to determine whether 31
integrin-mediated signals from LN-10/11 could rescue A549
cells from apoptosis induced by serum deprivation. We describe
here that LN-10/11 has more survival potential than FN. The
second goal was to identify pathway(s) that transduce the
survival signals from LN-10/11. We report that survival signals
from LN-10/11 are mainly through the PI 3-kinase/Akt path-
way, whereas survival signals from FN are conveyed by MEK1/
ERK through FAK.
EXPERIMENTAL PROCEDURES
Cells and Cell Culture—A549 human lung adenocarcinoma cells and
HeLa S3 human cervix adenocarcinoma cells were maintained in
DMEM supplemented with 10% fetal bovine serum at 37 °C in a hu-
midified atmosphere containing 5% CO2.
Reagents and Antibodies—PD98059 (a specific MEK1 inhibitor) and
wortmannin (a PI 3-kinase inhibitor) were purchased from Sigma. The
caspase inhibitor I, z-VAD-FMK (z-Val-Ala-Asp-fluromethylketone,
hereafter referred to as z-VAD), was obtained from Calbiochem. The
DeadEnd Colorimetric Apoptosis Detection kit for the TUNEL assay
was purchased from Promega (Madison, WI). Monoclonal anti-phospho-
ERK1/2 as well as polyclonal anti-phospho-Akt and anti-Akt were pur-
chased from New England BioLabs, Inc. (Beverly, MA). Monoclonal
anti-FAK and anti-MEK1 were obtained from Transduction Laborato-
ries (San Diego, CA). Polyclonal anti-ERK1/2 was from Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA). Site-specific polyclonal antibodies
against FAK specifically phosphorylated at Tyr-397, -407, -576, -577, or
-925 were obtained from BIOSOURCE International (Camarillo, CA).
Monoclonal anti-HA was purchased from Babco (Richmond, CA), and
monoclonal antibodies against FLAG (M2) and VSV were from Sigma.
Preparation of LN-10/11 and FN—LN-10/11 was purified to homo-
geneity from conditioned media of A549 cells as previously described
(34). Monoclonal antibody 5D6 recognizing the human laminin 5
chain was used for immunoaffinity chromatography as described (37).
FN was purified from human plasma by gelatin-Sepharose affinity
chromatography.
Expression Plasmids—VSV-tagged FAK and VSV-tagged FRNK
were generated from the green fluorescent protein vector pGZ21xZ
(38) by excision of the green fluorescent protein marker and the adja-
cent Kozak sequence using ClaI and BamHI and replacement by a
PCR-generated insert flanked by ClaI and BamHI sites containing a
Kozak consensus sequence, two adjacent repeats of the VSV epitope,
and either full-length mouse FAK (to generate VSV-FAK) or FAK
nucleotides 2185–3268 (VSV-FRNK); the fidelity of each construct was
confirmed by DNA sequencing. FLAG-Cas and FLAG-SD-Cas were
constructed as described (38). The expression plasmid for the dominant
negative HA-tagged MEK1 (HA-MEK1) was kindly provided by
Dr. Natalie G. Ahn (Department of Chemistry and Biochemistry, Uni-
versity of Colorado); transfection of A549 cells with this construct
decreased the level of ERK activation by 80% when assayed 10 min
after plating on fibronectin by immunoblotting with anti-phospho-
ERK1/2. Dominant-negative Akt (Akt-K179A) in the pCIS2 expression
vector was provided by Dr. Michael J. Quon (Hypertension-Endocrine
Branch, NIDDK, National Institutes of Health). The puromycin resist-
ance plasmid pHA262pur was provided by Dr. Hein te Riele (The
Netherlands Cancer Institute, Amsterdam).
Transfection and Cell Selection—Thirty g of each expression plas-
mid was co-transfected with 5 g of pHA262Puro into 3  106 A549 cells
by electroporation at 170 V and 960 microfarads with a Bio-Rad Gene
Pulser (Hercules, CA). To increase expression of transfected genes, 5
mM sodium butyrate was included in the culture medium. Cells were
subcultured at a 1:3 dilution 12 h after transfection and maintained for
48 h in 1 g/ml puromycin-containing medium. Before use, cells were
cultured overnight in the absence of puromycin.
TUNEL Assay and Cell Viability—The TUNEL assay for labeling
breaks in DNA strands was performed using the DeadEnd Colorimetric
Apoptosis Detection kit (Promega). Samples were prepared according to
the manufacturer’s protocol. In brief, glass coverslips were coated with
LN-10/11 (10 nM), FN (40 nM), or poly-L-lysine (PLL; 100 nM) in PBS
overnight at 4 °C, and then nonspecific binding sites were blocked with
1% BSA. The coating concentration of FN was 4-fold higher than that of
LN-10/11 to attain comparable levels of cell-adhesive activity for A549
cells (36). A549 cells were serum-starved overnight and then replated
on the coverslips and incubated for specified times in DMEM containing
1% BSA. Cells were then fixed with 4% paraformaldehyde in PBS for 25
min and permeabilized with 0.2% Triton X-100 for 5 min at room
temperature. After washing with PBS, the coverslips were incubated
with biotinylated nucleotide mixture with terminal deoxynucleotidyl
transferase enzyme; incorporated nucleotides were detected using dia-
minobenzidine and hydrogen peroxide and developed until there was a
light brown background. Apoptotic nuclei were stained brown.
To assess loss of cell viability, the proportion of nonviable cells was
determined by a trypan blue exclusion assay. Briefly, A549 cells were
serum-starved overnight, detached with trypsin-EDTA, and kept in
suspension in DMEM containing 1% BSA for 90 min. Cells were plated
on dishes coated with either LN-10/11 or FN in serum-free DMEM with
or without chemical inhibitors as indicated. At the times indicated, cells
were harvested with trypsin-EDTA and then stained by trypan blue or
photographed by phase-contrast microscopy. Comparisons with results
of the TUNEL assay confirmed that rounded cells with a bright circum-
ference indicative of high refractility by phase-contrast microscopy were
all apoptotic cells, which were also nonviable cells that stained with
trypan blue.
Western Blotting—After 24 h of serum starvation, A549 cells were
detached from culture dishes with 0.05% trypsin-EDTA, washed with
serum-free DMEM containing 1% BSA, and resuspended in the same
medium. Cells were kept in suspension for 90 min at 37 °C on a rotator.
5  105 cells were allowed to spread on 35-mm tissue culture dishes
coated with 5 nM LN-10/11 or 20 nM FN for the indicated times. After
washing in ice-cold PBS, cells were solubilized in 250 l of 1% Triton
lysis buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM
EGTA, 2.5 mM sodium pyrophosphate, 1 mM -glycerophosphate, 1 mM
sodium vanadate, 10 g/ml leupeptin, 10 g/ml aprotinin, and 1 mM
phenymethylsulfonyl fluoride). The cell lysates were clarified by cen-
trifugation at 20,000  g for 15 min at 4 °C. Immunoblots for phospho-
ERK, phospho-Akt, ERK, Akt or site-specific tyrosine-phosphorylated
FAK epitopes were visualized by ECL (Amersham Biosciences).
RESULTS
Integrin-mediated Survival Signals from LN-10/11 Prevent
Apoptosis Induced by Serum Depletion—Many epithelial cells
require appropriate cell-ECM interactions for survival, and
they undergo apoptosis in the absence of anchorage to the
basement membrane (39). To determine whether LN-10/11 was
able to serve as a survival ligand, cells were plated on sub-
strates coated with LN-10/11, FN, or PLL in serum-free me-
dium and then subjected to the TUNEL assay for apoptosis
after specific periods of time. Cells cultured on PLL started to
die even 7 h after replating, with 30% of the cells becoming
rounded and positively stained by this apoptosis assay, while
more than 90% of the cells plated on FN or LN-10/11 remained
spread and were negative for the assay (Fig. 1). After 20 h of
incubation in the absence of serum, cells on PLL underwent
apoptosis near the maximal level, but a majority of cells on
LN-10/11 and FN remained spread and viable. However, after
27 h of incubation, not only cells on PLL but also a number of
those on FN displayed a rounded morphology and underwent
apoptosis. In contrast, most of the cells on LN-10/11 remained
spread and viable, demonstrating that survival signal(s) from
LN-10/11 are more potent than from FN in A549 cells. The
prolonged cell survival on LN-10/11 but not on PLL was also
observed with HeLa S3 cells (data not shown). We also found
that the percentage of apoptotic cells as determined by TUNEL
assay was nearly identical to the percentage of rounded,
brightly phase-refractile cells, making it practical to use the






















percentage of rounded, phase-bright cells as an index of apo-
ptotic cell death.
Serum Depletion-induced Apoptosis Is Caspase-dependent—
There is extensive evidence for the involvement of caspases in
apoptosis (15, 16, 40). To confirm whether the apoptosis in-
duced by serum depletion was caspase-dependent, A549 cells
were cultured on FN in the presence of z-VAD, a broad spec-
trum caspase inhibitor. As expected, cells cultured on FN in the
presence of z-VAD remained spread and viable, as was the case
for the cells on LN-10/11 in the absence of z-VAD (Fig. 2A). The
percentage of apoptotic cells was significantly decreased from
87 to 15% when cells were plated on FN and incubated in the
serum-free medium containing z-VAD (Fig. 2B), indicating that
the apoptosis induced by serum removal is caspase-dependent.
LN-10/11 and FN Selectively Activate Akt and ERK Path-
ways—Several lines of evidence indicate that activation of PI
3-kinase/Akt or ERK pathways can block various apoptotic
stimuli (8, 13–17, 27, 41). To explore the role of these signaling
pathways in anchorage-dependent survival of cells, we exam-
ined the levels of activated Akt and ERK in cells adhering to
LN-10/11 or FN in the absence of serum. Adhesion to LN-10/11
induced a rapid and strong stimulation of Akt; a high level of
activated Akt persisted up to 1 h, followed by decline over 27 h
(Fig. 3A). A low but significant level of activated Akt was still
detectable after 27 h of incubation in the absence of serum. In
contrast, Akt was only moderately activated on FN, with a peak
at 10 min after replating. The levels of activated Akt on FN
declined rapidly to undetectable levels within 3 h after replat-
ing (Fig. 3A). The stimulation of Akt on both substrates was
completely blocked by wortmannin, a specific inhibitor of PI
3-kinase (Fig. 3A), indicating that the activation of Akt on
LN-10/11 and FN was PI 3-kinase-dependent.
Unlike the activation of Akt, levels of activated ERK were
slightly higher in cells adhering to FN than those to LN-10/11
over the period of 27-h incubation (Fig. 3B). Phosphorylated
ERK was detectable even after 20–27 h of incubation on FN but
not on LN-10/11. Although the levels of activated Akt and ERK
in the cells stably adhering to LN-10/11 or FN were low and
often only faintly detectable, it should be emphasized that both
preferential activation of Akt on LN-10/11 and that of ERK on
FN were reproducibly observed in repeated experiments.
Inhibition of PI 3-Kinase/Akt and MEK1/ERK Pathways
Differentially Facilitates Apoptosis on FN and LN-10/11—Al-
though both LN-10/11 and FN serve as cell survival factors,
they may suppress apoptosis by triggering separate signaling
pathways. To further explore the roles of the PI 3-kinase/Akt
and MEK1/ERK pathways in cell survival on LN-10/11 and FN,
we examined the effects of wortmannin and PD98059, specific
inhibitors of PI 3-kinase and MEK1, respectively. Blockade of
Akt activation by wortmannin was found to facilitate cell death
on LN-10/11, as evidenced by the emergence of rounded cells
with phase-bright circumferences, but it did not significantly
affect cell death on FN (Fig. 4). The percentage of apoptotic
cells increased from 4 to 53% on LN-10/11 upon treatment
with wortmannin. In contrast, treatment with PD98059 signif-
icantly increased the percentage of rounded, apoptotic cells on
FN but exerted only a marginal effect on the viability of cells
FIG. 1. LN-10/11 protects A549 cells against apoptosis induced
by serum depletion. A, serum-starved A549 cells were allowed to
spread on coverslips coated with PLL (100 nM), FN (40 nM), or LN-10/11
(10 nM) for 7 h (left panel) or 27 h (right panel) in DMEM containing 1%
BSA. After fixation and permeabilization, cells were incubated with
biotinylated nucleotide mixture, followed by incubation with streptavi-
din horseradish peroxidase and then with diaminobenzidine and hydro-
gen peroxide as described under “Experimental Procedures.” The ar-
rowheads indicate apoptotic cells stained brown. B, the data show the
percentage of apoptotic cells quantified and expressed as the mean from
two independent experiments.
FIG. 2. Serum deprivation-induced apoptosis is caspase-
dependent. A, serum-starved A549 cells were detached and then re-
plated on 24-well culture dishes coated with FN (20 nM, left and middle
panel) or LN-10/11 (5 nM, right panel) in 1% BSA medium with (middle
panel) or without (left and right panels) 20 M z-VAD. The coating
concentrations of FN and LN-10/11 were reduced by half to obtain
comparable cell-adhesive activity as obtained on glass coverslips. After
incubation for 27 h, cells were photographed using a phase-contrast
microscope. The rounded, phase-refractile cells shown in the left panel
were considered apoptotic and nonviable as described under “Experi-
mental Procedures.” B, the percentages of apoptotic cells were quanti-
fied and expressed as the mean  S.D. from three independent
experiments.






















adhering to LN-10/11 (Fig. 4). These results suggest that LN-
10/11 and FN differentially rescue serum deprivation-induced
apoptosis by preferentially activating PI 3-kinase/Akt and
MEK1/ERK pathways, respectively.
LN-10/11-mediated Survival Is Linked to the PI 3-kinase/Akt
Pathway, whereas FN-mediated Survival Is Linked to the
MEK1/ERK Pathway—To assess further the role of PI 3-ki-
nase/Akt and MEK1/ERK pathways in the antiapoptotic ac-
tions of LN-10/11 and FN, we overexpressed dominant negative
mutants of Akt (DN-Akt) and MEK1 (DN-MEK1) to test
whether these DN mutants could mimic the effects of wortman-
nin and PD98059, respectively. We cotransfected a puromycin
resistance plasmid with DN-Akt or DN-MEK1 and then se-
lected transfectants for 2 days in medium containing puromy-
cin. This puromycin selection procedure routinely yields 90%
positive populations of transfectants as previously described
(38). The surviving cells were cultured in medium containing
10% fetal bovine serum without puromycin overnight and
starved in medium without serum for an additional 24 h. These
selected cells were then replated on LN-10/11 or FN-coated
substrates for cell viability assays. Consistent with the results
shown in Fig. 4, overexpression of DN-Akt substantially in-
creased the percentage of nonviable cells to 84% on LN-10/11,
but only 30% of the cells became apoptotic on FN (Fig. 5A).
Conversely, transfection with DN-MEK1 significantly potenti-
ated cell apoptosis on FN but not on LN-10/11. Immunoblot
quantification of DN-Akt and DN-MEK1 relative to their en-
dogenous counterparts showed that the levels of DN-Akt and
DN-MEK1 were 3- and 4-fold greater than those of endogenous
Akt and MEK1, respectively (Fig. 5B). Taken together, these
results strongly indicate that LN-10/11 and FN differentially
FIG. 3. Activation of Akt and ERK in cells adhering to LN-10/11
and FN. Serum-starved A549 cells were detached and maintained in
suspension for 90 min and then replated on dishes coated with LN-
10/11 (5 nM) or FN (20 nM) for the indicated times. Cell lysates were
subjected to 10% SDS-PAGE. After electroblotting, blots were analyzed
for phosphorylated Akt (P-Akt; A) and ERK (P-ERK; B) as well as total
Akt (T-Akt; A) and ERK (T-ERK; B). PD, PD98059; Wort, wortmannin.
C, densitometric quantification of the levels of phosphorylated Akt and
ERK. The data are shown as -fold increases relative to the levels of the
unstimulated control (i.e. cells before plating) after normalization
against the levels of T-Akt and T-ERK. The data shown are the means
of three separate experiments.
FIG. 4. Wortmannin and PD98059 selectively block survival
signals from LN-10/11 and FN. A, serum-starved A549 cells were
detached and replated on dishes coated with LN-10/11 (5 nM, upper
panel) or FN (20 nM, lower panel) in 1% BSA medium without (left
panel) or with 50 nM wortmannin (middle panel) or 20 nM PD98059
(right panel) for 20 h and then were photographed by phase-contrast
microscopy. The percentage of rounded cells was taken as an index of
apoptosis. B, data shown are the mean  S.D. from three independent
experiments.
FIG. 5. Effects of dominant-negative mutants on cell viability.
A549 cells were cotransfected with pHA262pur with or without DN-
Akt, DN-MEK1, VSV-FAK, VSV-FRNK, FLAG-Cas, or FLAG-Cas-SD.
After selection with puromycin, cells were serum-starved for 24 h. Cells
were detached and replated on dishes coated with LN-10/11 (5 nM) or
FN (20 nM) in 1% BSA medium for 20 h, and then viable cells were
quantified by phase-contrast microscopy. A, data shown are the mean 
S.D. from three independent experiments. B, the expression levels of
DN-Akt (a), DN-MEK1 (b), VSV-FAK and VSV-FRNK (c), or FLAG-Cas
and FLAG-Cas-SD (d) were detected by immunoblotting (IB) with
anti-Akt, anti-MEK1, anti-VSV, and anti-FLAG antibodies, respec-
tively. Ctr, cells transfected with pHA262pur alone.






















protect cells from apoptosis induced by serum removal through
distinct signaling pathways.
FAK Is Not Critically Involved in Survival Signals from
LN-10/11—FAK plays a central role in linking integrin recep-
tors to intracellular signaling pathways (23). To determine
whether FAK is required for the antiapoptotic action of FN or
LN-10/11, we cotransfected FAK or FRNK with the puromycin
resistance plasmid. The expression level of recombinant FRNK
was found to be 4-fold greater than the level of recombinant
FAK (Fig. 5B); levels of the latter were comparable with those
of endogenous FAK (data not shown). Transfection of FAK
alone did not alter cell viability on either FN- or LN-10/11-
coated substrates. Expression of FRNK, however, significantly
potentiated serum depletion-induced apoptosis of cells adher-
ing to FN, whereas only a small increase in cell death was
observed with cells adhering to LN-10/11 (Fig. 5A). These re-
sults indicated that FAK is involved in FN-mediated, but not
LN-10/11-mediated, survival signaling.
We also examined the role of p130cas in cell survival signal-
ing pathways on FN or LN-10/11 by cotransfecting cells with
plasmids for p130cas or its mutant form lacking the substrate
domain (Cas-SD) with the selectable puromycin resistance
plasmid. The expression levels of wild-type p130cas and its
mutant Cas-SD were comparable (Fig. 5B) and 2-fold
greater than that of endogenous p130cas, as determined by
immunoblotting with anti-p130cas antibody (data not shown).
Expression of Cas-SD reduced the viability of cells adhering
to both FN- and LN-10/11-coated substrates (Fig. 5A), suggest-
ing that phosphorylation of p130cas is an important mediator of
survival signals on both LN-10/11 and FN.
To investigate further whether FAK is needed for survival
signals on LN-10/11, we examined FAK phosphorylation pat-
terns using a panel of polyclonal antibodies recognizing tyro-
sine phosphorylation of FAK at Tyr-397, -407, -576, -577, and
-925. There were no apparent differences in the phosphoryla-
tion levels of any of the tyrosine residues between cells on
LN-10/11 and FN except for Tyr-397; the level of the Tyr-397
phosphorylation was much lower in cells adhering to LN-10/11
than in cells adhering to FN (Fig. 6). These results, together
with the data shown in Fig. 5, strongly suggest that phospho-
rylation of FAK is not critically involved in transmitting sur-
vival signals on LN-10/11, in contrast to its role in FN-depend-
ent protection from apoptosis.
DISCUSSION
The 31 integrin-mediated signaling events triggered by
cell adhesion to LN-10/11 are quite different from those trig-
gered by adhesion to FN. LN-10/11 preferentially activates
Rac, but not Rho, through an 31 integrin-dependent pathway
involving a p130cas-CrkII-DOCK180 complex, thereby strongly
promoting cell migration through enhanced formation of lamel-
lipodia. FN, however, preferentially activates Rho rather than
Rac, leading to enhanced stress fiber and focal contact forma-
tion (36). In this study, we analyzed intracellular signaling
pathways regulating cell survival of A549 human lung adeno-
carcinoma cells by focusing on two distinct signaling pathways
involving PI 3-kinase/Akt and MEK1/ERK; although separate,
these pathways might potentially engage in cross-talk. We
found that LN-10/11 is more potent than FN in suppressing
apoptosis induced by serum deprivation. The antiapoptotic ef-
fects of LN-10/11 could be inhibited by the PI 3-kinase inhibitor
wortmannin, whereas the antiapoptotic effects of FN were in-
hibited by the MEK1 inhibitor PD98059; these contrasting
findings indicate that different ECMs selectively modulate dif-
ferent intracellular signaling pathways to sustain cell survival.
These findings were further confirmed by expression of domi-
nant negative Akt and MEK1, which compromised the ability
of LN-10/11 and FN to transduce survival signals, respectively.
Our results provide clear evidence that different signaling
pathways leading to cell survival are activated on different
ECM ligands (i.e. on FN and LN-10/11) (Fig. 7). Since laminins
are the major components of the basement membrane of epi-
thelium, our work supports the notion that a function of the
basement membrane is to provide distinctive cell survival sig-
nals for establishment and maintenance of epithelial tissue.
LN-10/11 Is More Potent Than FN in Protecting Cells against
Apoptosis-induced by Serum Depletion—Interactions of cells
with the ECM through integrins are known to suppress apo-
ptosis in many cell types. Mammary epithelial cells cultured on
collagen I show extensive apoptosis over periods of several
days, whereas the same cells do not when in contact with LN-1
or Matrigel, a basement membrane-like gel containing lami-
nin-1, collagen IV, nidogen, and perlecan (39). However, LN-1
may not be a survival ligand for other cells, since endothelial
cells undergo apoptosis on an LN-1 substrate while being pro-
tected from apoptosis on FN or vitronectin substrates (24).
Thus, different cell types may have their own favored ECM for
protection from apoptosis, depending on the repertoire of inte-
FIG. 6. Differential phosphorylation of FAK on LN-10/11 and
FN. Serum-starved A549 cells were detached and held in suspension for
90 min and then replated on dishes coated with LN-10/11 (5 nM) or FN
(20 nM) and incubated for the indicated times. Cell lysates were sub-
jected to 8% SDS-PAGE, followed by immunoblotting (IB) with poly-
clonal antibodies against FAK phosphorylated at Tyr-397, -407, -576,
-577, or –925. Total quantities of FAK (T-FAK) were also determined
using anti-FAK antibody (bottom panel) to demonstrate equal amounts
of loaded protein. 0 min, cells kept in suspension.
FIG. 7. Proposed scheme of distinct survival signaling path-
ways on LN-10/11 and FN. Cell adhesion to ECM triggers integrin-
mediated tyrosine phosphorylation of FAK and p130cas, leading to ac-
tivation of downstream cascades involving PI 3-kinase/Akt and MEK1/
ERK that prevent apoptosis. LN-10/11 preferentially induces
phosphorylation of p130cas, whereas FN induces phosphorylation of
FAK (Ref. 36; also this study). The survival signals from LN-10/11 are
mainly through the PI 3-kinase/Akt pathway, whereas FN survival
signals are conveyed by FAK through the MEK1/ERK pathway. Cross-
talk between PI 3-kinase and Rac has been described (43, 44) (dashed
lines). Recently, it has been shown that Rho activation may contribute
to sustained ERK activation (48) (dashed line). Cross-talk has also been
reported between FAK and PI 3-kinase (12, 21) (dashed line), although
this process was not observed in the present study.






















grins expressed on their cell surface, which in turn may define
the types of ECM ligands most potent for protection from
apoptosis. Our present studies are based on comparisons of the
signaling events and abilities of LN-10/11 and FN to rescue
A549 cells from serum depletion-induced apoptosis. Since 31
and 51 integrins serve as the dominant adhesion receptors
for LN-10/11 and FN, respectively, the distinct apoptotic re-
sponses of cells on LN-10/11 and FN mirror the distinct signal-
ing pathways downstream of the 31 and 51 integrins (Fig.
7). Our data show that LN-10/11 is more potent than FN in
preventing apoptosis induced by serum depletion, suggesting
that the 31 integrin transduces potent survival signals when
bound to LN-10/11. This is consistent with the closely over-
lapped distribution of 31 integrin and its major ligand LN-
10/11. In fact, the 31 integrin is predominantly expressed on
many kinds of epithelial cells that deposit laminin-10 and
laminin-11 as the major components of their basement mem-
brane. It should be noted, however, that signaling pathways on
distinct ECM ligands are usually context-dependent and may
not be the same in different cell types. Our conclusions based
on analyses of A549 lung carcinoma cells remain to be gener-
alized to other cell types.
PI 3-Kinase/Akt Pathway Is Essential for LN-10/11 Survival
Signals—Cell adhesion to ECM triggers integrin-mediated
downstream phosphorylation cascades involving the ERK type
of mitogen-activated protein kinase and PI 3-kinase, providing
possible mechanisms for ECM-dependent cell survival (1, 2). It
remains to be determined, however, whether the survival sig-
nals from different ECM ligands are transduced by distinct
signaling pathways. Activation of the PI 3-kinase/Akt pathway
provided a potent antiapoptotic signal in cells adhering to
LN-10/11, whereas activation of the MEK1/ERK pathway was
necessary for survival of cells adhering to FN. To our knowl-
edge, this is the first report to provide a clear distinction
between the signaling pathways that rescue a cell from apo-
ptosis on different ECM ligands.
Accumulating evidence indicates that the PI 3-kinase/Akt
pathway is critical for preventing apoptosis (42). Anoikis re-
sulting from denial of integrin-mediated adhesion involves re-
duced signaling through the PI 3-kinase/Akt pathway (42). Our
results show that the 31 integrin, when compared with 51,
selectively activates the PI 3-kinase/Akt pathway, thereby ex-
erting its potent antiapoptotic effects. The evidence for a spe-
cific connection between 31 integrin and the PI 3-kinase/Akt
pathway includes the facts that the antiapoptotic effects of
LN-10/11 but not FN are reversed by wortmannin or expression
of a dominant-negative Akt mutant. The stronger activation of
Rac in cells adhering to LN-10/11 than in those adhering to FN
(36) may also contribute to enhance cell survival on LN-10/11;
Rac activation has been shown to protect epithelial cells
against anoikis through activation of the PI 3-kinase/Akt path-
way (43, 44), although the precise mechanisms of the cross-talk
between PI 3-kinase and Rac in cell survival remain to be
clarified. Protection of Madin-Darby canine kidney cells from
anoikis by overexpression of a membrane-anchored, constitu-
tively activated form of FAK has been described (10); the mech-
anism might involve cross-talk activation between the hyper-
activated FAK and PI 3-kinase pathways (45) or some
alternative mechanism.
Our results do not imply that the 31 integrin is the only
integrin capable of activating the PI 3-kinase/Akt pathway,
since cell type-specific differences are known. Mammary epi-
thelial cells utilize the 61 integrin to transduce cell survival
signals that are dependent on the PI 3-kinase/Akt pathway (8).
In contrast to our results, 51 integrin regulation of cell sur-
vival in rat intestinal epithelial cells has been shown to mod-
ulate the PI 3-kinase/Akt pathway (14), whereas our data
showed that FN protected A549 cells against apoptosis mainly
through the MEK1/ERK pathway. The central role of the
MEK1/ERK pathway in survival of A549 cells on FN was
supported by the proapoptotic effects of PD98059 or the over-
expression of dominant negative MEK1 mutant on cells adher-
ing to FN. Consistent with our observations, the Ras/mitogen-
activated protein kinase cascade has been shown to function as
a survival signaling pathway; thus, sustained activation of this
pathway efficiently rescues fibroblasts and epithelial cells from
anoikis (15). Besides PI 3-kinase/Akt and ERK pathways, ac-
tivation of c-Jun NH2-terminal kinase has also been shown to
be involved in apoptosis (46, 47). Almeida et al. (18) reported
that activation of the c-Jun NH2-terminal kinase pathway, but
not the PI 3-kinase/Akt or ERK signaling pathways, is essen-
tial for protecting primary rabbit synovial fibroblasts against
apoptosis induced by serum depletion on FN-coated substrates,
indicating that distinct signaling pathways play critical roles in
integrin-mediated survival signals.
Prolonged Activation of Akt or ERK Is Substrate-dependent—
Although this study showed that the initial activation of Akt or
ERK (e.g. 10 min after replating; see Fig. 3) was observed in
cells adhering to either LN-10/11 or FN, prolonged basal acti-
vation of Akt or ERK was observed only in cells adhering to
LN-10/11 or to FN, respectively. The basal levels of activated
Akt and/or ERK seem to be important for protecting cells
against apoptosis induced by serum removal, as demonstrated
by the experiments using wortmannin and PD98059 and ex-
pression of their dominant negative mutants. The precise
mechanisms of specific activation of Akt and ERK by different
ECM ligands remain to be elucidated. Several lines of evidence
indicate that integrins with different  subunits activate mito-
gen-activated protein kinases via different signaling pathways
(1). For example, a subset of integrins including the 51 inte-
grin can recruit the transmembrane protein caveolin-1 and the
adaptor protein Shc, thereby activating the ERK pathway.
Recently, it has been reported that Rho has an essential role in
integrin- and growth factor receptor-mediated signaling path-
ways that lead to sustained ERK activation and subsequent
cyclin D1 regulation (48). Thus, the prolonged basal activation
of ERK on FN could be explained by the observations that in
certain cells, FN preferentially activates Rho but not Rac,
whereas LN-10/11 preferentially activates Rac but not Rho
(36). The  subunits of 31 and 61 associate with a group of
TM4SF proteins (49). The TM4SF proteins may associate with
protein kinase C and phosphatidylinositol 4-kinase, linking
these integrins to phosphoinositide signaling pathways (50). It
remains to be examined, however, whether TM4SF proteins
are involved in the prolonged basal activation of Akt on LN-
10/11 via association with 31.
FN Survival Signals Are FAK-dependent, whereas LN-10/11
Survival Signals Are FAK-independent—A rapid increase in
the tyrosine phosphorylation of FAK at multiple sites has been
identified as a prominent early event in integrin-mediated cell
adhesion that regulates cell proliferation, migration, and
apoptosis (23, 51). Autophosphorylation of FAK at Tyr-397 has
emerged as a crucial event in FAK-mediated signal transduc-
tion, since the phosphorylation of FAK at Tyr-397 triggers the
formation of molecular complexes with other signaling proteins
including Src family kinases (52, 53), the p85 regulatory sub-
unit of PI 3-kinase (54), Shc (55), and tumor suppressor PTEN
(38, 56). Our data showed that FAK phosphorylation at Tyr-
397 was more prominently induced in cells adhering to FN
than to LN-10/11, supporting the previous observation that the
level of overall tyrosine phosphorylation of FAK was lower in
cells adhering to LN-10/11 than in those adhering to FN (36).






















Together with the observation that expression of FRNK sub-
stantially impaired survival of cells on FN with minimal effects
when cells were on LN-10/11, our results suggest that FAK is
an essential component in survival signaling on FN but not on
LN-10/11.
The role of FAK in integrin-mediated ERK activation is
complex. Schlaepfer et al. (55, 57) found that FAK was involved
in integrin-triggered ERK signaling, but differing findings
have been reported in other systems (24–26). Since the time
course of phosphorylation of FAK did not correlate with the
time course of ERK activation (Figs. 3 and 6), FAK may act
collaboratively by other mechanisms with other signaling mol-
ecules to ensure prolonged basal activation of ERK on FN. In
fact, B-Raf has been shown to be required for the sustained
activation of ERK in a FAK-dependent manner (58). On the
other hand, p130cas appeared to be involved in both LN-10/11
and FN survival signaling pathways, since the expression of
p130cas lacking the substrate domain significantly reduced cell
viability on both LN-10/11 and FN. Consistent with this obser-
vation, the role of p130cas in integrin 31-dependent Rac acti-
vation on LN-10/11 has been demonstrated (36), while the
involvement of p130cas in integrin 51-dependent ERK activa-
tion has also been demonstrated in different cell types (58).
In conclusion, our results strongly suggest that different
ligands differentially activate integrin-mediated signaling
pathways to protect against apoptosis in A549 cells, although it
remains to be examined whether the distinct signaling path-
ways transduced by those different ECMs exist in other cell
types. LN-10/11 was more potent than FN for protection
against apoptosis induced by serum depletion by selectively
activating the PI 3-kinase/Akt pathway rather than the MEK1/
ERK pathway. The importance of anchorage to the basement
membrane is well established for the maintenance of epithelial
architecture and survival of epithelial cells; this study provides
insight into the molecular basis of basement membrane-trig-
gered signaling events regulating epithelial cell function.
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